Guido Sauter

Research interests

Publications

• Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories

  Cancer Cell · 2018 · 10.1016/j.ccell.2018.10.016

• Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

  Nature Biotechnology · 2016 · 10.1038/nbt.3605

• Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer

  Cancer Cell · 2013 · 10.1016/j.ccr.2013.01.002

• Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

  American Journal Of Pathology · 2012 · 10.1016/j.ajpath.2012.04.026

• Adjuvant Trastuzumab in HER2-Positive Breast Cancer

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa0910383

• Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2007.14.8197

• Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer

  Nature Genetics · 2007 · 10.1038/ng2006

• Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

  British Journal of Cancer · 2006 · 10.1038/sj.bjc.6602924

• Prevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers

  American Journal Of Pathology · 2004 · 10.1016/s0002-9440(10)63731-5

• Frequent EpCam protein expression in human carcinomas

  Human Pathology · 2004 · https://doi.org/10.1016/j.humpath.2003.08.026

• Arterial Neovascularization and Inflammation in Vulnerable Patients

  Circulation · 2004 · 10.1161/01.cir.0000146787.16297.e8

• Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer

  Cancer Research · 2004 · 10.1158/0008-5472.can-04-1945

• Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast

  Oncogene · 2003 · 10.1038/sj.onc.1206199

• POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

  PubMed · 2003

• Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity

  Nature Genetics · 2002 · 10.1038/ng894

• Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

  American Journal Of Pathology · 2002 · 10.1016/s0002-9440(10)64476-8

• Impact of DNA amplification on gene expression patterns in breast cancer.

  PubMed · 2002

• Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studies

  The Journal of Pathology · 2001 · 10.1002/path.893

• Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints

  American Journal Of Pathology · 2001 · https://doi.org/10.1016/s0002-9440(10)63075-1

• Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma

  Cancer · 2000 · 10.1002/1097-0142(20000801)89:3<604::aid-cncr16>3.0.co;2-q

• Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients

  Human Pathology · 2000 · https://doi.org/10.1053/hp.2000.6698

• High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma

  American Journal Of Pathology · 1999 · 10.1016/s0002-9440(10)65349-7

• Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays

  JNCI Journal of the National Cancer Institute · 1999 · 10.1093/jnci/91.20.1758

• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  Nature Medicine · 1998 · https://doi.org/10.1038/nm0798-844

• AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer

  Science · 1997 · https://doi.org/10.1126/science.277.5328.965

Current projects

No projects listed.